SLC2A1 and prostate cancer: Additionally, high GLUT1 expression is closely related to the occurrence and prognosis of various malignant tumors such as non-small cell lung cancer, prostate cancer, oral squamous cell carcinoma, ovarian cancer, bladder cancer, pancreatic cancer, and melanoma.